Ubs Group Ag Cortexyme, Inc. Transaction History
Ubs Group Ag
- $555 Billion
- Q2 2025
A detailed history of Ubs Group Ag transactions in Cortexyme, Inc. stock. As of the latest transaction made, Ubs Group Ag holds 2,846 shares of CRTX stock, worth $3,671. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,846
Previous 706
303.12%
Holding current value
$3,671
Previous $0
Infinity%
% of portfolio
0.0%
Previous 0.0%
Shares
23 transactions
Others Institutions Holding CRTX
# of Institutions
46Shares Held
8.43MCall Options Held
97KPut Options Held
0-
Nantahala Capital Management, LLC New Canaan, CT2.53MShares$3.26 Million0.14% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.45MShares$1.88 Million0.0% of portfolio
-
Epiq Capital Group, LLC San Francisco, CA825KShares$1.06 Million0.31% of portfolio
-
Ieq Capital, LLC439KShares$566,6580.0% of portfolio
-
Geode Capital Management, LLC Boston, MA397KShares$512,1060.0% of portfolio
About Cortexyme, Inc.
- Ticker CRTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,150,800
- Market Cap $70.5M